Bodycote reported first-half core organic revenue growth of 9.6%, driven by strong demand in aerospace and defense, industrial gas turbines, medical, and semiconductor-related markets, while automotive weakness persisted. Core operating profit rose 11% organically to £60.4 million, and core operating margin increased 30 basis points to 16.2%. Group revenue, including non-core businesses being exited, grew 6.5% organically to £381.2 million, with group operating profit of £61 million and group operating margin up 110 basis points to 16%. Adjusted earnings per share rose 18.3% to 25.2 pence, and the interim dividend was increased 4%. The company reaffirmed its full-year expectations and expects growth to moderate in the second half due to tougher prior-year comparisons, particularly in aerospace.
Bodycote PLCStrong demand in aerospace, defense, industrial gas turbines, medical, and semiconductor markets drove 9.6% core organic revenue growth.